Cite
HARVARD Citation
Nikoloudis, A. et al. (2023). Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate‐ but not mycophenolate‐ or post‐transplant cyclophosphamide‐based graft versus host disease prophylaxis. European journal of haematology. pp. 715-724. [Online].